Biotest AG (BIESF)

PNK: BIESF · Real-Time Price · USD

32.00

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

Biotest Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	107.8M	108.1M	116.6M	104.4M	71.3M	60.8M	61.9M	22.3M	72.9M
Short-Term Investments	11.7M	10.4M	20M	13.1M	17.9M	24.9M	44.2M	5.9M	10M
Long-Term Investments	-9.6M	11.3M	-14.9M	-8.6M	-15.3M	-23M	-42.3M	2.2M	-5.7M
Other Long-Term Assets	27.3M	148.9M	33.6M	19.2M	18.6M	38.2M	51.8M	13.4M	18.5M
Receivables	201.9M	196.8M	159.7M	146.4M	162.1M	145.8M	149.3M	133.8M	164.7M
Inventory	479.5M	419.1M	293.8M	244.6M	290.1M	280.1M	208.3M	146.9M	170.8M
Other Current Assets	7M	22.1M	36.9M	12.3M	20.5M	1.4M	60.4M	146.1M	47.5M
Total Current Assets	809.5M	756.5M	619.4M	522.2M	556.3M	522.8M	495.1M	449.7M	467.2M
Property-Plant & Equipment	570.8M	475.7M	547.8M	550M	548.2M	547.9M	512.7M	477.1M	414.9M
Goodwill & Intangibles	16.5M	8.1M	16.4M	11.2M	14M	13.8M	16.4M	16.6M	25.3M
Total Long-Term Assets	624.5M	654.4M	583.6M	582M	575M	585.6M	547.2M	528.8M	465.6M
Total Assets	1.43B	1.41B	1.2B	1.1B	1.13B	1.11B	1.04B	978.5M	932.8M
Account Payables	88.4M	78.1M	51.1M	38.8M	42M	52.2M	73.4M	65M	62.8M
Deferred Revenue	n/a	600K	64.8M	56.9M	49.8M	47.8M	46.4M	39.6M	39.1M
Short-Term Debt	200K	226.8M	4.8M	30M	21.3M	3.5M	500K	119.4M	16M
Other Current Liabilities	59.7M	67.4M	4.9M	-33.6M	32M	7.5M	-13.7M	27M	27.9M
Total Current Liabilities	160.1M	385.3M	130.2M	106.4M	105.6M	115M	125.6M	251.2M	146M
Long-Term Debt	538.5M	329.5M	540.5M	474.4M	439.5M	380.2M	325.6M	283.5M	326.6M
Other Long-Term Liabilities	150.6M	144.8M	135.6M	121M	121.6M	113.6M	92.8M	3.9M	4.4M
Total Long-Term Liabilities	743.2M	526.7M	701.7M	617.4M	584.1M	516.5M	421.5M	379.5M	426.1M
Total Liabilities	903.3M	912M	831.9M	723.8M	689.7M	631.5M	547.1M	630.7M	572.1M
Total Debt	597.2M	614.1M	574.3M	496.3M	469.1M	409.6M	329.4M	406.4M	346.2M
Common Stock	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M
Retained Earnings	274.5M	239.5M	111.7M	121M	182.2M	217.5M	235.6M	88.2M	101.1M
Comprehensive Income	n/a	1.1M	-2M	-2M	-2.9M	-3.9M	-4.2M	29.9M	37.6M
Shareholders Equity	530.7M	498.9M	371.1M	380.4M	441.6M	476.9M	495M	347.6M	360.5M
Total Investments	2.1M	11.3M	5.1M	4.5M	2.6M	1.9M	1.9M	8.1M	4.3M